{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:40:22Z","timestamp":1781116822566,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.pnpbp.2006.08.002","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T15:18:44Z","timestamp":1158679124000},"page":"123-130","source":"Crossref","is-referenced-by-count":30,"title":["Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals"],"prefix":"10.1016","volume":"31","author":[{"given":"Bankole A.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Roache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassima","family":"Ait-Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda T.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Dawes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Qun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2006.08.002_bib1","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0306-4603(03)00082-0","article-title":"Methamphetamine use behaviors and gender differences","volume":"29","author":"Brecht","year":"2004","journal-title":"Addict Behav"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/BF00216011","article-title":"Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic\u2013noradrenergic interactions","volume":"91","author":"Cole","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib4","first-page":"129","article-title":"Forebrain norepinephrine: role in controlled information processing in the rat","volume":"7","author":"Cole","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00002826-200307000-00010","article-title":"Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophrenia","volume":"26","author":"Deutsch","year":"2003","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/REVNEURO.1994.5.1.27","article-title":"Modulation of brain dopamine transmission by sex steroids","volume":"5","author":"Di Paolo","year":"1994","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1212\/WNL.27.8.783","article-title":"Memory and cognitive function in man: does the cholinergic system have a specific role?","volume":"27","author":"Drachman","year":"1977","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib8","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.54.6.1344","article-title":"Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study","volume":"54","author":"Ernst","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.2000.tb00283.x","article-title":"Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy","volume":"41","author":"Fujikawa","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib10","series-title":"Drug addiction II: amphetamine, psychotogen, and marihuana dependence","first-page":"247","article-title":"Effects of amphetamine in humans","author":"Gunne","year":"1977"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib11","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0028-3908(87)90066-9","article-title":"Behavioral pharmacology of central nervous system stimulants","volume":"26","author":"Harvey","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib12","series-title":"Drug addiction and its treatment: nexus of neuroscience and behavior","first-page":"137","article-title":"Neurobiological basis of drug reinforcement","author":"Hemby","year":"1997"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib13","series-title":"Pulse check: national trends in drug abuse","author":"Hunt","year":"1995"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00008877-199605000-00002","article-title":"Effects of GR 68755 on d-amphetamine-induced changes in mood, cognitive performance, appetite, food preference, and caloric and macronutrient intake in humans","volume":"7","author":"Johnson","year":"1996","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002130051007","article-title":"Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: a preliminary study","volume":"144","author":"Johnson","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0893-133X(99)00116-5","article-title":"Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on d-methamphetamine-induced cognitive and physiological changes in humans","volume":"22","author":"Johnson","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib17","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomised controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib18","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/archinte.165.14.1600","article-title":"Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial","volume":"165","author":"Johnson","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00213-004-1998-0","article-title":"Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition","volume":"178","author":"Johnson","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib20","unstructured":"Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Wallace CL, Dawes MA, et al. (in press). Effects of acute topiramate dosing on methamphetamine-induced subjective mood. Int J Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2006.08.002_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000124461","article-title":"Effect of ovarian steroids to stimulate region-specific hypothalamic 5-hydroxytryptamine synthesis in ovariectomized rats","volume":"42","author":"King","year":"1986","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib23","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.yebeh.2004.06.017","article-title":"Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication","volume":"5","author":"Kockelmann","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/0091270003251837","article-title":"Clinical pharmacology of topiramate versus lamotrigine versus phenobarbital: comparison of efficacy and side effects using odds ratios","volume":"43","author":"Lathers","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1345\/aph.1A398","article-title":"The use of topiramate in mood stabilization","volume":"36","author":"Maidment","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib26","series-title":"Generalized, linear, and mixed models","author":"McCulloch","year":"2001"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3758\/BF03203313","article-title":"An automated version of the digit symbol substitution test (DSST)","volume":"14","author":"McLeod","year":"1982","journal-title":"Behav Res Methods Instrum Comput"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1037\/1064-1297.5.3.203","article-title":"Ethanol and pentobarbital: comparison of behavioral and subjective effects in sedative drug abusers","volume":"5","author":"Mintzer","year":"1997","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/seiz.2001.0604","article-title":"Unilateral striatal damage following status epilepticus of ipsilateral frontal lobe origin","volume":"11","author":"Morioka","year":"2002","journal-title":"Seizure"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib30","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1360-0443.2004.00707.x","article-title":"A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence","volume":"99","author":"Rawson","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00004714-199302000-00002","article-title":"Differential effects of triazolam and ethanol on awareness, memory, and psychomotor performance","volume":"13","author":"Roache","year":"1993","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0165-1781(02)00111-7","article-title":"Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals","volume":"111","author":"Salo","year":"2002","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004850-199200710-00005","article-title":"Ondansetron, a 5-HT3 receptor antagonist, partially attenuates the effects of amphetamine: a pilot study in healthy volunteers","volume":"7","author":"Silverstone","year":"1992","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/ana.410200616","article-title":"Hemispheric brain damage in unilateral status epilepticus","volume":"20","author":"Soffer","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib35","series-title":"Pharmacology of the states of alertness","first-page":"189","article-title":"Effects of amphetamines on performance and on polygraphic sleep parameters in man","author":"Spiegel","year":"1979"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1440-1614.1999.00518.x","article-title":"Amphetamine withdrawal: II. A placebo-controlled, randomised, double-blind study of amineptine treatment","volume":"33","author":"Srisurapanont","year":"1999","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib37","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1046\/j.1528-1157.2001.41700.x","article-title":"Postmarketing experience with topiramate and cognition","volume":"42","author":"Tatum","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib38","unstructured":"U.S. Department of Health and Human Services. The DAWN report. Washington, DC: The Substance Abuse and Mental Health Services Administration (SAMHSA), Drug Abuse Warning Network (DAWN); 2001."},{"key":"10.1016\/j.pnpbp.2006.08.002_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1176\/appi.ajp.158.3.377","article-title":"Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers","volume":"158","author":"Volkow","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1300\/J069v21n01_05","article-title":"Use ecology and drug use motivations of methamphetamine users admitted to substance abuse treatment facilities in Los Angeles: an emerging profile","volume":"21","author":"von Mayrhauser","year":"2002","journal-title":"J Addict Dis"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib41","first-page":"1","article-title":"Enhancement of human performance by caffeine and the amphetamines","volume":"14","author":"Weiss","year":"1962","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pnpbp.2006.08.002_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0376-8716(98)00063-5","article-title":"Drug-activation of brain reward pathways","volume":"51","author":"Wise","year":"1998","journal-title":"Drug Alcohol Depend"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606003228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606003228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T03:52:18Z","timestamp":1547351538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584606003228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0278584606003228"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2006.08.002","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}